A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Protein and carbohydrate–based insulin dosing doesn't improve glycemic control compared with carbohydrate-based dosing alone in people with type 1 diabetes (T1D). Postprandial glycemic control in ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes had a higher time in range if they usually administered bolus insulin after a missed ...

Real-world use of the MiniMed 780G (MM780G) system is associated with effective glycemic control on days when users do not administer bolus insulin, achieving a mean time in range of 70.9%. Real-world ...

COPENHAGEN, Denmark & PALO ALTO, Calif.--(BUSINESS WIRE)--Glooko, Inc. and Hedia today announced the launch of their interoperable solution, which combines connected care, remote patient monitoring, ...

COLUMBIA, Md., March 17, 2026--(BUSINESS WIRE)--Welldoc ®, a leader in AI-powered cardiometabolic health solutions, today announced new real-world evidence (RWE) demonstrating improved time in range ...

Tandem has finally made its long-awaited app-based Mobile Bolus feature available to insulin pump users thanks to a newly-released set of updates. We tried it ourselves to see how the first ...